A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
|Articles|August 18, 2015
Hope Rugo on Managing Effects From Ovarian Suppression in Patients With Breast Cancer
Author(s)Hope S. Rugo
Hope S. Rugo discusses managing effects from ovarian suppression treatment for breast cancer.
Advertisement
Hope S. Rugo, from the University of California, San Francisco (UCSF), Helen Diller Family Comprehensive Cancer Center, discusses managing effects from ovarian suppression treatment for breast cancer.
Advertisement
Related to this article
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
A woman treated for DCIS breast cancer with a double mastectomy shares why her smoother recovery left her with survivor guilt and feeling like an impostor.
Dr. Sara Hurvitz explains why giving Enhertu before surgery didn't change care for HER2-low, HR-positive early breast cancer, and what patients should know.
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
3
Enhertu Before Surgery Falls Short in HER2-Low Early Breast Cancer
4
Glioblastoma Genomic Testing: What Patients Should Ask
5